Literature DB >> 14972527

Neutralizing human monoclonal antibodies to hepatitis A virus recovered by phage display.

Sang Jick Kim1, Myeong Hee Jang, Jack T Stapleton, Sun Ok Yoon, Keun-Soo Kim, Eun-Seok Jeon, Hyo Jeong Hong.   

Abstract

Four human monoclonal antibodies (MAbs) to hepatitis A virus (HAV) were isolated from a phage-displayed antibody library constructed from the peripheral blood lymphocytes (PBLs) of HAV-immune donors. The four MAbs showed differences in their affinity: two (HA6, HA9) of them were dominant after four rounds of panning, and showed higher affinity than the other two (HA1, HA12). All four MAbs showed HAV-neutralizing activity in radioimmunofocus inhibition assay and their neutralizing activity was positively correlated with their affinities. Analysis of their epitope specificity by cross-competition binding assays suggested that HA6 and HA9 recognize extensively overlapping epitopes, which overlap with those of HA1 and HA12, although HA1 and HA12 recognize distinct epitopes. In addition, competition assays with known neutralizing murine MAbs suggested that the epitopes of four human MAbs extensively overlap with those of B5B3 and K34C8 which are distinct but reside within the single, immunodominant neutralization site on the HAV capsid. The human MAbs (HA6 and HA9) with highest affinity may be useful in the immunoprophylaxis of HAV infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14972527     DOI: 10.1016/j.virol.2003.10.014

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  11 in total

1.  Human Monoclonal Fab Antibodies Against West Nile Virus and its Neutralizing Activity Analyzed in Vitro and in Vivo.

Authors:  Tao Duan; Monique Ferguson; Lintian Yuan; Fangling Xu; Guangyu Li
Journal:  J Antivir Antiretrovir       Date:  2009-11-01

2.  Structural basis for potent cross-neutralizing human monoclonal antibody protection against lethal human and zoonotic severe acute respiratory syndrome coronavirus challenge.

Authors:  Barry Rockx; Davide Corti; Eric Donaldson; Timothy Sheahan; Konrad Stadler; Antonio Lanzavecchia; Ralph Baric
Journal:  J Virol       Date:  2008-01-16       Impact factor: 5.103

3.  Phage display on the base of filamentous bacteriophages: application for recombinant antibodies selection.

Authors:  N V Tikunova; V V Morozova
Journal:  Acta Naturae       Date:  2009-10       Impact factor: 1.845

4.  The first human epitope map of the alphaviral E1 and E2 proteins reveals a new E2 epitope with significant virus neutralizing activity.

Authors:  Ann R Hunt; Shana Frederickson; Toshiaki Maruyama; John T Roehrig; Carol D Blair
Journal:  PLoS Negl Trop Dis       Date:  2010-07-13

5.  Generation of “LYmph Node Derived Antibody Libraries” (LYNDAL) for selecting fully human antibody fragments with therapeutic potential.

Authors:  Philipp Diebolder; Armin Keller; Stephanie Haase; Anne Schlegelmilch; Jonathan D Kiefer; Tamana Karimi; Tobias Weber; Gerhard Moldenhauer; Roland Kehm; Anna M Eis-Hübinger; Dirk Jäger; Philippe A Federspil; Christel Herold-Mende; Gerhard Dyckhoff; Roland E Kontermann; Michaela A E Arndt; Jürgen Krauss
Journal:  MAbs       Date:  2014 Jan-Feb       Impact factor: 5.857

Review 6.  Severe acute respiratory syndrome (SARS): development of diagnostics and antivirals.

Authors:  Morten Draeby Sørensen; Brian Sørensen; Regina Gonzalez-Dosal; Connie Jenning Melchjorsen; Jens Weibel; Jing Wang; Chen Wie Jun; Yang Huanming; Peter Kristensen
Journal:  Ann N Y Acad Sci       Date:  2006-05       Impact factor: 5.691

Review 7.  Phage display-based strategies for cloning and optimization of monoclonal antibodies directed against human pathogens.

Authors:  Nicola Clementi; Nicasio Mancini; Laura Solforosi; Matteo Castelli; Massimo Clementi; Roberto Burioni
Journal:  Int J Mol Sci       Date:  2012-07-04       Impact factor: 6.208

8.  An efficient strategy for cell-based antibody library selection using an integrated vector system.

Authors:  Hyerim Yoon; Jin Myung Song; Chun Jeih Ryu; Yeon-Gu Kim; Eun Kyo Lee; Sunghyun Kang; Sang Jick Kim
Journal:  BMC Biotechnol       Date:  2012-09-18       Impact factor: 2.563

9.  Extension of the in vivo half-life of endostatin and its improved anti-tumor activities upon fusion to a humanized antibody against tumor-associated glycoprotein 72 in a mouse model of human colorectal carcinoma.

Authors:  Sang-Hyun Lee; In Cheul Jeung; Tae Woo Park; Kyungmin Lee; Dong Gwang Lee; Young-Lai Cho; Tae Sup Lee; Hee-Jun Na; Young-Jun Park; Hee Gu Lee; Mun Sik Jeong; Kwang-Hee Bae; Sang Chul Lee; Hyo Jin Lee; Young-Guen Kwon; Hyo Jeong Hong; Jang-Seong Kim; Jeong-Ki Min
Journal:  Oncotarget       Date:  2015-03-30

10.  Functional recombinant human anti-HAV antibody expressed in milk of transgenic mice.

Authors:  Ran Zhang; Man Rao; Chuan Li; Jingyuan Cao; Qinglin Meng; Min Zheng; Meili Wang; Yunping Dai; Mifang Liang; Ning Li
Journal:  Transgenic Res       Date:  2009-01-08       Impact factor: 2.788

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.